The Foundation supports research that can lead to the creation of better Parkinson's treatments. Here you can search previously awarded grants by keyword, program name, researcher name, institution or organization name and/or year.
FUNDED GRANTS ( 2)
Alpha-synuclein Imaging, 2011
The ultimate goal of this project is develop a positron emission tomography (PET) radiotracer to image the distribution of alpha-synuclein in the brain. Alpha-synuclein imaging would be a valuable biomarker that could be used for diagnosis (potentially pre-symptomatic), drug development, and monitoring of disease progression and therapeutic effects.
Alpha-Synuclein Imaging, 2008
In Vivo SPECT Imaging of Alpha-Synuclein Aggregation with Morphology Specific Antibody Based Ligands
The protein alpha-synuclein is a major constituent of the Lewy Body aggregates that are a hallmark feature of Parkinson's disease and has been strongly correlated with the disease. Small a-synuclein aggregates are very toxic and may be an early indicator of the disease. We will develop ligands that can specifically label different forms of alpha-synuclein so that we can study ...
Researchers: Michael Sierks, PhD